Oncology medicines
Oncology is the core of our business. We supply the cancer medicines that day-care units, tertiary cancer centres and oncology pharmacies run out of first — and we keep the biologics cold the whole way.
Our oncology portfolio covers cytotoxic chemotherapy, monoclonal antibodies and other biologics, immunotherapies, oral targeted therapies, hormonal therapies and the supportive-care medicines given alongside them, such as growth factors, antiemetics and bone-protective agents.
Because we buy directly from innovator multinationals and from India’s leading generic and biosimilar manufacturers, a hospital can choose between the original brand and a quality-assured Indian alternative for the same molecule. That choice matters for patients who pay out of pocket and for institutions working within tender budgets.
We already supply some of India’s best-known cancer institutions, including Tata Memorial Hospital and ACTREC in Mumbai, the Gujarat Cancer & Research Institute in Ahmedabad, and the Homi Bhabha Cancer Hospitals in Varanasi and Muzaffarpur.
What we supply in oncology
Cytotoxic chemotherapy
Platinum agents, taxanes, anthracyclines, antimetabolites and alkylating agents, in vials and oral forms.
Monoclonal antibodies & biosimilars
HER2, VEGF, CD20 and EGFR-directed antibodies, in original brands and approved biosimilars.
Immunotherapy
PD-1 and PD-L1 checkpoint inhibitors for solid tumours.
Oral targeted therapy
Tyrosine kinase inhibitors, PARP inhibitors and CDK4/6 inhibitors.
Hormonal therapy
Breast and prostate cancer hormonal agents, including depot injections.
Supportive care
G-CSF, erythropoietins, antiemetics, bone-protective agents and mesna.
Commonly requested oncology molecules
A reference list, not a live stock list. Most molecules are available in more than one brand — add what you need and our team confirms stock, brand options and rate.
| Molecule | Class | Typical storage | Action |
|---|---|---|---|
| Trastuzumab | HER2 monoclonal antibody | 2–8 °C | |
| Pertuzumab | HER2 monoclonal antibody | 2–8 °C | |
| Trastuzumab emtansine | Antibody–drug conjugate | 2–8 °C | |
| Bevacizumab | Anti-VEGF monoclonal antibody | 2–8 °C | |
| Rituximab | Anti-CD20 monoclonal antibody | 2–8 °C | |
| Cetuximab | Anti-EGFR monoclonal antibody | 2–8 °C | |
| Pembrolizumab | PD-1 checkpoint inhibitor | 2–8 °C | |
| Nivolumab | PD-1 checkpoint inhibitor | 2–8 °C | |
| Atezolizumab | PD-L1 checkpoint inhibitor | 2–8 °C | |
| Durvalumab | PD-L1 checkpoint inhibitor | 2–8 °C | |
| Daratumumab | Anti-CD38 monoclonal antibody | 2–8 °C | |
| Bortezomib | Proteasome inhibitor | Room temp. | |
| Lenalidomide | Immunomodulator | Room temp. | |
| Pomalidomide | Immunomodulator | Room temp. | |
| Azacitidine | Hypomethylating agent | Room temp. | |
| Paclitaxel | Taxane chemotherapy | Room temp. | |
| Docetaxel | Taxane chemotherapy | Varies by brand | |
| Carboplatin | Platinum chemotherapy | Room temp. | |
| Cisplatin | Platinum chemotherapy | Room temp. | |
| Oxaliplatin | Platinum chemotherapy | Room temp. | |
| Gemcitabine | Antimetabolite | Room temp. | |
| Pemetrexed | Antifolate | Room temp. | |
| Capecitabine | Oral fluoropyrimidine | Room temp. | |
| Fluorouracil (5-FU) | Antimetabolite | Room temp. | |
| Doxorubicin | Anthracycline | Varies by brand | |
| Cyclophosphamide | Alkylating agent | Room temp. | |
| Temozolomide | Oral alkylating agent | Room temp. | |
| Imatinib | Tyrosine kinase inhibitor | Room temp. | |
| Osimertinib | EGFR tyrosine kinase inhibitor | Room temp. | |
| Gefitinib | EGFR tyrosine kinase inhibitor | Room temp. | |
| Palbociclib | CDK4/6 inhibitor | Room temp. | |
| Ribociclib | CDK4/6 inhibitor | Room temp. | |
| Olaparib | PARP inhibitor | Room temp. | |
| Everolimus | mTOR inhibitor | Room temp. | |
| Letrozole | Aromatase inhibitor | Room temp. | |
| Fulvestrant | Oestrogen-receptor degrader | 2–8 °C | |
| Goserelin | LHRH agonist implant | Room temp. | |
| Zoledronic acid | Bisphosphonate | Room temp. | |
| Denosumab | RANKL monoclonal antibody | 2–8 °C | |
| Filgrastim | G-CSF | 2–8 °C | |
| Pegfilgrastim | Long-acting G-CSF | 2–8 °C | |
| Palonosetron | 5-HT3 antiemetic | Room temp. | |
| Fosaprepitant | NK1 antiemetic | 2–8 °C | |
| Mesna | Uroprotectant | Room temp. | |
| Calcium folinate (leucovorin) | Folate rescue | Room temp. |
Storage shown is typical for the molecule; always follow the product label. Don’t see a product? and we will check.
Oncology questions
Do you supply both branded and biosimilar oncology medicines?
Yes. For most monoclonal antibodies we can offer the innovator brand and one or more approved Indian biosimilars, so the hospital or patient can choose on clinical preference and budget.
How are oncology biologics shipped?
Biologics travel in validated insulated shippers that hold 2–8 °C for the full transit time, packed with a temperature data logger. The receiving pharmacy can see the temperature record for that consignment.
Can a patient buy oncology medicines from you directly?
We supply against a valid prescription and can arrange delivery to the patient’s nearest chemist or hospital pharmacy. Call or WhatsApp us with the prescription and we will advise on availability.
Other therapy areas
Send us your requirement the way you already work
Most hospitals and chemists send a list on WhatsApp. You can also build one on this site, call, or email. We confirm availability, brand options and rates, usually the same working day.